Nuclear Oncology Fellowship Program

Welcome to the Nuclear Oncology Fellowship training program at Stanford University. We strive to educate the next generation of worldwide leaders in academic and clinical theragnostics. The program includes education in basic sciences, diagnostic imaging and therapy as they relate to Nuclear Oncology. In particular, there is holistic education related to clinical management of theragnostic patients with a focus on integrating radiopharmaceutical therapies with other cancer therapies. Ample research opportunities are provided to take advantage of resources such as the Molecular Imaging Program at Stanford (MIPS) and the Research PET/MRI Program at Stanford. Clinical training takes place at Stanford Health Care, Lucile Packard Children’s Hospital at Stanford and the VA Palo Alto Health Care System. At the end of the fellowship, trainees are encouraged to successfully sit for the ABNM examinations.

The program is a one-year non-ACGME accredited fellowship for which there is one position. Qualified applicants will have an MD degree or DO degree and will have successfully completed training and board eligibility in nuclear medicine, radiology or combined nuclear medicine/radiology programs by the time the fellowship begins. Additionally, candidates must be eligible to obtain a Physicians and Surgeons California Medical License, which is required prior to the start of fellowship. Please refer to the Medical Board of California website for eligibility information prior to submitting your application for fellowship. 

For the 2026-27 academic year, the position is funded in part by a grant from the Society of Nuclear Medicine and Molecular Imaging Mars Shot. As such, the successful applicant must have these characteristics:

*Qualified candidates must be US or Canadian, SNMMI member, unrestricted licensed physicians who have completed training in Nuclear Medicine, Nuclear Radiology, or Diagnostic Radiology, preference to those who are board certified/eligible in Nuclear Medicine. (Applicant must be on a path to Authorized User status to administer radiopharmaceutical therapies).

Contact
Ann Vo
Nuclear Oncology Fellowship Coordinator
Email: annvo@stanford.edu